GlassScriptPhysician profile
Robert M Harris
NPI 1134126378
$176,930.25
in general payments reported to CMS, 2019-2025
34 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $15K · 2021: $77K · 2022: $69K · 2023: $292 · 2024: $150 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $156,612.48 | 2020-2023 | Blastx, Xperience, Surgx |
| Citieffe, INC. | $13,635.49 | 2019 | |
| Acumed LLC | $2,299.62 | 2021-2022 | |
| Cgg Medical INC | $1,024.04 | 2019-2021 | |
| Cerapedics INC. | $800.00 | 2022 | |
| My01 INC. | $599.78 | 2022-2024 | My01 Continuous Compartmental Pressure Monitor |
| Depuy Synthes Sales INC. | $336.05 | 2019-2025 | Na, Va-Lcp, Tfn-Advance |
| Stryker Corporation | $267.61 | 2019-2025 | 1788 |
| Carbofix Orthopedics INC | $140.49 | 2022-2025 | |
| Vericel Corporation | $122.23 | 2020 | |
| Pacira Therapeutics, INC. | $114.94 | 2019-2020 | |
| Prosidyan, INC | $101.60 | 2021 | |
| Smith+Nephew, INC. | $97.53 | 2019-2022 | |
| Skeletal Dynamics INC | $92.11 | 2025 | Geminus, Implate, Align |
| Amgen INC. | $89.88 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $74.47 | 2022-2023 | Photodynamic Bone Stabilization Procedure Pack |
| Pacira Pharmaceuticals Incorporated | $68.50 | 2019 | |
| Globus Medical, INC. | $66.71 | 2022-2023 | Sable |
| Zimmer Biomet Holdings, INC. | $43.89 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $37.10 | 2024-2025 | Strensiq |
| Orthofix Medical, INC. | $36.02 | 2022 | |
| Bioventus LLC | $33.37 | 2023 | Nexus, Sonicone Clinic |
| Paragon 28, INC. | $32.51 | 2019-2020 | |
| Trevena, INC. | $24.44 | 2021 | |
| Boston Scientific Corporation | $24.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $22.72 | 2023 | Andexxa |
| Kci USA, INC. | $21.31 | 2021 | |
| Si-Bone, INC. | $20.95 | 2025 | |
| Radius Health, INC. | $20.82 | 2020 | |
| Integra Lifesciences Corporation | $19.84 | 2020 | |
| Osteomed LLC | $17.50 | 2022 | |
| Glaxosmithkline, LLC. | $17.35 | 2022 | |
| Allergan, INC. | $14.77 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.